Renal Cancer - Results from #7820

Clinical and safety profile of high-dose interleukin-2 treatment in elderly patients with metastatic melanoma and renal cell carcinoma - Abstract April 4, 2013

Malignant priapism due to metastatic papillary renal cell carcinoma : A case report - Abstract April 4, 2013

Small renal cell carcinomas and synchronous metastases - Abstract April 3, 2013

Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma - Abstract April 3, 2013

Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: A single institution retrospective study - Abstract April 3, 2013

Dietary supplement hymecromone and sorafenib: A novel combination for the control of renal cell carcinoma - Abstract April 3, 2013

Prolonged natural progression from localized to symptomatic renal cell carcinoma - Abstract April 2, 2013

Metastatic renal cell carcinoma in an ovarian benign mixed mucinous cystadenoma and Brenner tumour: A case report - Abstract April 2, 2013

Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy - Abstract April 2, 2013

Metastasis of renal cell carcinoma to contralateral adrenal gland: Case report and review of the literature - Abstract April 2, 2013

Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: A SEER analysis - Abstract March 29, 2013

Intraoperative EBRT and resection for renal cell carcinoma : Twenty-year outcomes - Abstract March 29, 2013

The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size - Abstract March 29, 2013

Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma? - Abstract March 28, 2013

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: A cohort study - Abstract March 28, 2013

Survival prediction in everolimus-treated patients with metastatic renal cell carcinoma incorporating tumor burden response in the RECORD-1 trial - Abstract March 28, 2013

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma - Abstract March 28, 2013

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: Results from the REDECT trial - Abstract March 28, 2013

Treatment experience of the metastatic renal cell carcinomas to the head and neck region in our department - Abstract March 27, 2013

The role of metastasectomy in renal cell carcinoma in the era of targeted therapy - Abstract March 26, 2013

Page 392 of 456